UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver ...

UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver disease associated with obesity and type 2 diabetes that affects more than ...

A clinical trial showed CAR-T cell therapy may shrink aggressive brain and spinal cord tumours in young patients. View on ...

Results demonstrate statistically significant fibrosis reversal and protection against hepatocellular carcinoma in animal models of MASH –– ...

The research, led by Professor Fatima Bosch, director of the UAB Center of Animal Biotechnology and Gene Therapy (CBATEG), professor of the Department of Biochemistry and Molecular Biology at the UAB ...

UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver disease associated with ...

His research includes identification of prognostic/predictive epigenetic and molecular markers for clinical outcome, response ...

1 Department of Medicine, University of California at Los Angeles, Los Angeles, California 2 Departments of Molecular Pharmacology and Urology, University of California at Los Angeles, Los Angeles ...

An immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant in a Stanford ...

In drug discovery, targeted protein degradation is a method that selectively eliminates disease-causing proteins. A ...

CAR-T therapy leverages the body’s immune system to target and ... being the most prominent and widely used [15]. qPCR is a ...

Led by Maurizio Pellecchia, a professor of biomedical sciences in the UCR School of Medicine, the team found that the degraders, which were made in the lab, act like "molecular crowbars" that open up ...